Diana Do, MD, professor of ophthalmology at Stanford University, discussed her presentation on the comparison of the efficacy of multiple anti-VEGF treatments in wet AMD at the virtual American Academy of Ophthalmology annual meeting.
Results from a network meta-analysis of 21 randomized trials showed no clinically significant differences in dosing regimens or anti-VEGF agents in visual acuity outcomes at 12- and 24-month intervals.
After examining best visual acuity outcomes at 12 and 24 months, Do and colleagues then evaluated a proportion of patients who gained 15 or more letters.
“We
Uncategorized